ORGAN AND TISSUE TRANSPLANTATION

The project is on a tight timeline with an expectation under the CFAST grant funding that it will be completed in August, 2016. The mitigation plan includes an experienced core team (experienced project manager and metadata developers) and support from FDA, industry and academia, as well as re-use of concepts from Diabetes, Diabetic Kidney Disease and Polycystic Kidney Disease therapeutic area ... ................
................